Search Results - "Body, Jean‐Jacques"

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody by von Moos, Roger, Costa, Luis, Gonzalez-Suarez, Eva, Terpos, Evangelos, Niepel, Daniela, Body, Jean–Jacques

“…•Bone is a common site of metastasis, particularly in breast and prostate cancer.•Bisphosphonates reduce skeletal-related events in patients with bone…”
Get full text

Prediction of an Imminent Fracture After an Index Fracture – Models Derived From the Frisbee Cohort by Iconaru, Laura, Charles, Alexia, Baleanu, Felicia, Surquin, Murielle, Benoit, Florence, Mugisha, Aude, Moreau, Michel, Paesmans, Mairanne, Karmali, Rafix, Rubinstein, Michel, Rozenberg, Serge, Body, Jean‐Jacques, Bergmann, Pierre

“…ABSTRACT Patients who sustain a fracture are at greatest risk of recurrent fracture during the next 2 years. We propose three models to identify subjects most…”
Get full text

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS by Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques

“…Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) in patients with bone…”
Get full text

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia by Jan de Beur, Suzanne M., Minisola, Salvatore, Xia, Wei‐bo, Abrahamsen, Bo, Body, Jean‐Jacques, Brandi, Maria Luisa, Clifton‐Bligh, Roderick, Collins, Michael, Florenzano, Pablo, Houillier, Pascal, Imanishi, Yasuo, Imel, Erik A., Khan, Aliya A., Zillikens, M. Carola, Fukumoto, Seiji

“…Tumor‐induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by mesenchymal tumors that secrete fibroblast growth factor 23 (FGF23). Patients…”
Get full text

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT by Kinnard, Virginie, Baleanu, Felicia, Iconaru, Laura, Moreau, Michel, Paesmans, Marianne, Body, Jean‐Jacques, Bergmann, Pierre

Get full text

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study by Stopeck, Alison T, Lipton, Allan, Body, Jean-Jacques, Steger, Guenther G, Tonkin, Katia, de Boer, Richard H, Lichinitser, Mikhail, Fujiwara, Yasuhiro, Yardley, Denise A, Viniegra, María, Fan, Michelle, Jiang, Qi, Dansey, Roger, Jun, Susie, Braun, Ada

“…This randomized study compared denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor κ B (RANK) ligand, with zoledronic…”
Get full text

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases by Rozenberg, Serge, Body, Jean-Jacques, Bruyère, Olivier, Bergmann, Pierre, Brandi, Maria Luisa, Cooper, Cyrus, Devogelaer, Jean-Pierre, Gielen, Evelien, Goemaere, Stefan, Kaufman, Jean-Marc, Rizzoli, René, Reginster, Jean-Yves

“…Dairy products provide a package of essential nutrients that is difficult to obtain in low-dairy or dairy-free diets, and for many people it is not possible to…”
Get full text

Increased fracture rate in women with breast cancer: a review of the hidden risk by Body, Jean-Jacques

“…Women with breast cancer, particularly individuals diagnosed at a relatively early age, have an increased incidence of fractures. Fractures can have serious…”
Get full text

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates by FIZAZI, Karim, LIPTON, Allan, MARIETTE, Xavier, BODY, Jean-Jacques, RAHIM, Yasmin, GRALOW, Julie R, GUOZHI GAO, LING WU, SOHN, Winnie, JUN, Susie

“…Patients with bone metastases and elevated urinary N-telopeptide (uNTx), representing excessive bone resorption, are at increased risk for skeletal-related…”
Get full text

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review by Nicolatou-Galitis, Ourania, Kouri, Maria, Papadopoulou, Erofili, Vardas, Emmanouil, Galiti, Dimitra, Epstein, Joel B., Elad, Sharon, Campisi, Giuseppina, Tsoukalas, Nikolaos, Bektas-Kayhan, Kivanc, Tan, Winston, Body, Jean-Jacques, Migliorati, Cesar, Lalla, Rajesh V.

“…Introduction The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such…”
Get full text

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club by Laurent, Michaël R, Goemaere, Stefan, Verroken, Charlotte, Bergmann, Pierre, Body, Jean-Jacques, Bruyère, Olivier, Cavalier, Etienne, Rozenberg, Serge, Lapauw, Bruno, Gielen, Evelien

“…Glucocorticoids are effective immunomodulatory drugs used for many inflammatory disorders as well as in transplant recipients. However, both iatrogenic and…”
Get full text

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid by CLEELAND, Charles S, BODY, Jean-Jacques, LIPTON, Allan, DE BOER, Richard, SALVAGNI, Stefania, TOSELLO OLIVEIRA, Celia, YI QIAN, QI JIANG, DANSEY, Roger, BRAUN, Ada, CHUNG, Karen, STOPECK, Alison, VON MOOS, Roger, FALLOWFIELD, Lesley, MATHIAS, Susan D, PATRICK, Donald L, CLEMONS, Mark, TONKIN, Katia, MASUDA, Norikazu

“…In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone metastases…”
Get full text

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer by Waqas, Komal, Lima Ferreira, Joana, Tsourdi, Elena, Body, Jean-Jacques, Hadji, Peyman, Zillikens, M.C.

“…•Aromatase inhibitors induce bone loss and increase fracture risk in early-stage breast cancer women.•BMD T-score < -2.0 SD or ≥ 2 clinical risk factors are an…”
Get full text

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure by Body, Jean‐Jacques, Lipton, Allan, Gralow, Julie, Steger, Guenther G, Gao, Guozhi, Yeh, Howard, Fizazi, Karim

“…Bone metastases place patients at increased risk of skeletal‐related events (SREs), including pathologic fractures, spinal cord compression, severe pain…”
Get full text

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG by Hadji, Peyman, Aapro, Matti S., Body, Jean-Jacques, Gnant, Michael, Brandi, Maria Luisa, Reginster, Jean Yves, Zillikens, M. Carola, Glüer, Claus-C., de Villiers, Tobie, Baber, Rod, Roodman, G. David, Cooper, Cyrus, Langdahl, Bente, Palacios, Santiago, Kanis, John, Al-Daghri, Nasser, Nogues, Xavier, Eriksen, Erik Fink, Kurth, Andreas, Rizzoli, Rene, Coleman, Robert E.

“…Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase…”
Get full text

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases by LIPTON, Allan, STEGER, Guenther G, COLEMAN, Robert, PATERSON, Alexander H. G, PETERSON, Mark C, FAN, Michelle, KINSEY, Amy, JUN, Susie, FIGUEROA, Jazmin, ALVARADO, Cristina, SOLAL-CELIGNY, Philippe, BODY, Jean-Jacques, DE BOER, Richard, BERARDI, Rossana, GASCON, Pere, TONKIN, Katia S

“…Denosumab, a fully human monoclonal antibody to receptor activator of nuclear factor-kappaB ligand, suppresses bone resorption. In this study, we evaluated the…”
Get full text

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe by Body, Jean-Jacques, von Moos, Roger, Rider, Alex, Hallworth, Pamela, Bhowmik, Debajyoti, Gatta, Francesca, Hechmati, Guy, Qian, Yi

“…Bone metastases (BMs) are common in patients with prostate cancer and can lead to skeletal-related events (SREs), which are associated with increased pain and…”
Get full text

Patient preferences for treatments to delay bone metastases by Hauber, A. Brett, Arellano, Jorge, Qian, Yi, González, Juan Marcos, Posner, Joshua D., Mohamed, Ateesha F., Gatta, Francesca, Tombal, Bertrand, Body, Jean-Jacques

“…BACKGROUND Most patients with advanced prostate cancer (PCa) develop bone metastases (BM) and present with bone complications like fracture. Bone‐targeted…”
Get full text

Bisphosphonates Induce Breast Cancer Cell Death In Vitro by Fromigue, Olivia, Lagneaux, Laurence, Body, Jean‐Jacques

“…Breast cancer frequently spreads to bone and is almost always associated with osteolysis. This tumor‐induced osteolysis is caused by increased osteoclastic…”
Get full text

Fibroblast growth factor 23 and its role in phosphate homeostasis by Ramon, Isolde, Kleynen, Pierre, Body, Jean-Jacques, Karmali, Rafik

“…Phosphate homeostasis is complex and incompletely understood. The identification of different factors involved in the regulation of phosphate balance, also…”
Get full text